203 related articles for article (PubMed ID: 10383727)
21. Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis.
Ling BC; Wu J; Miller SJ; Monk KR; Shamekh R; Rizvi TA; Decourten-Myers G; Vogel KS; DeClue JE; Ratner N
Cancer Cell; 2005 Jan; 7(1):65-75. PubMed ID: 15652750
[TBL] [Abstract][Full Text] [Related]
22. Conditional knockout of N-WASP in mouse fibroblast caused keratinocyte hyper proliferation and enhanced wound closure.
Jain N; Kalailingam P; Tan KW; Tan HB; Sng MK; Chan JS; Tan NS; Thanabalu T
Sci Rep; 2016 Dec; 6():38109. PubMed ID: 27909303
[TBL] [Abstract][Full Text] [Related]
23. A mild mutator phenotype arises in a mouse model for malignancies associated with neurofibromatosis type 1.
Garza R; Hudson RA; McMahan CA; Walter CA; Vogel KS
Mutat Res; 2007 Feb; 615(1-2):98-110. PubMed ID: 17208258
[TBL] [Abstract][Full Text] [Related]
24. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
Xu J; Ismat FA; Wang T; Yang J; Epstein JA
Circulation; 2007 Nov; 116(19):2148-56. PubMed ID: 17967772
[TBL] [Abstract][Full Text] [Related]
25. Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas.
Serra E; Rosenbaum T; Nadal M; Winner U; Ars E; Estivill X; Lázaro C
Nat Genet; 2001 Jul; 28(3):294-6. PubMed ID: 11431704
[TBL] [Abstract][Full Text] [Related]
26. MHC-class-II-deficiency impairs wound healing.
Schäffer M; Bongartz M; Hoffmann W; Viebahn R
J Surg Res; 2007 Mar; 138(1):100-5. PubMed ID: 17161429
[TBL] [Abstract][Full Text] [Related]
27. Mesenchymal stem cells' interaction with skin: wound-healing effect on fibroblast cells and skin tissue.
Jeon YK; Jang YH; Yoo DR; Kim SN; Lee SK; Nam MJ
Wound Repair Regen; 2010; 18(6):655-61. PubMed ID: 20955344
[TBL] [Abstract][Full Text] [Related]
28. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
[TBL] [Abstract][Full Text] [Related]
29. Perinatal or adult Nf1 inactivation using tamoxifen-inducible PlpCre each cause neurofibroma formation.
Mayes DA; Rizvi TA; Cancelas JA; Kolasinski NT; Ciraolo GM; Stemmer-Rachamimov AO; Ratner N
Cancer Res; 2011 Jul; 71(13):4675-85. PubMed ID: 21551249
[TBL] [Abstract][Full Text] [Related]
30. Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes.
Dasgupta B; Li W; Perry A; Gutmann DH
Cancer Res; 2005 Jan; 65(1):236-45. PubMed ID: 15665300
[TBL] [Abstract][Full Text] [Related]
31. Acute downregulation of connexin43 at wound sites leads to a reduced inflammatory response, enhanced keratinocyte proliferation and wound fibroblast migration.
Mori R; Power KT; Wang CM; Martin P; Becker DL
J Cell Sci; 2006 Dec; 119(Pt 24):5193-203. PubMed ID: 17158921
[TBL] [Abstract][Full Text] [Related]
32. Stimulation of fibroblast proliferation and matrix contraction by wound fluid.
Schäffer MR; Tantry U; Ahrendt GM; Wasserkrug HL; Barbul A
Int J Biochem Cell Biol; 1997 Jan; 29(1):231-9. PubMed ID: 9076958
[TBL] [Abstract][Full Text] [Related]
33. Stimulus-evoked release of neuropeptides is enhanced in sensory neurons from mice with a heterozygous mutation of the Nf1 gene.
Hingtgen CM; Roy SL; Clapp DW
Neuroscience; 2006; 137(2):637-45. PubMed ID: 16298082
[TBL] [Abstract][Full Text] [Related]
34. NF1 gene silencing induces upregulation of vascular endothelial growth factor expression in both Schwann and non-Schwann cells.
Kawachi Y; Maruyama H; Ishitsuka Y; Fujisawa Y; Furuta J; Nakamura Y; Ichikawa E; Furumura M; Otsuka F
Exp Dermatol; 2013 Apr; 22(4):262-5. PubMed ID: 23528211
[TBL] [Abstract][Full Text] [Related]
35. Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation.
Gutmann DH; Loehr A; Zhang Y; Kim J; Henkemeyer M; Cashen A
Oncogene; 1999 Aug; 18(31):4450-9. PubMed ID: 10442636
[TBL] [Abstract][Full Text] [Related]
36. P2Y2 R activation by nucleotides promotes skin wound-healing process.
Jin H; Seo J; Eun SY; Joo YN; Park SW; Lee JH; Chang KC; Kim HJ
Exp Dermatol; 2014 Jul; 23(7):480-5. PubMed ID: 24816122
[TBL] [Abstract][Full Text] [Related]
37. Neurofibromatosis type 1 (NF1): diagnosis and management.
Ferner RE; Gutmann DH
Handb Clin Neurol; 2013; 115():939-55. PubMed ID: 23931823
[TBL] [Abstract][Full Text] [Related]
38. The role of iNOS in wound healing.
Shi HP; Most D; Efron DT; Tantry U; Fischel MH; Barbul A
Surgery; 2001 Aug; 130(2):225-9. PubMed ID: 11490353
[TBL] [Abstract][Full Text] [Related]
39. Neurofibromin, the neurofibromatosis type 1 Ras-GAP, is required for appropriate P0 expression and myelination.
Rosenbaum T; Kim HA; Boissy YL; Ling B; Ratner N
Ann N Y Acad Sci; 1999 Sep; 883():203-14. PubMed ID: 10586246
[TBL] [Abstract][Full Text] [Related]
40. Neurofibromatosis type 1 is a disorder of dysplasia: the importance of distinguishing features, consequences, and complications.
Riccardi VM
Birth Defects Res A Clin Mol Teratol; 2010 Jan; 88(1):9-14. PubMed ID: 19691086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
